コンテンツへスキップ
Merck

HSTCMAG384-PX21

Millipore

MILLIPLEX® 384-well Human High Sensitivity T Cell Premixed 21-Plex Panel - Immunology Multiplex Assay

for the analysis of a combination of analytes in serum, plasma, or tissue/cell culture supernatant

別名:

High Sensitivity T Cell Kit, T Cell Panel 21-Plex

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12161503
eCl@ss:
32161000
NACRES:
NA.47

品質水準

交差性

human

メーカー/製品名

Milliplex®

assay range

accuracy: 79-108%
standard curve range: 0.18-750 pg/mL
(IL-6)

standard curve range: 0.24-1,000 pg/mL
(IL-13)

standard curve range: 0.24-1,000 pg/mL
(IL-21)

standard curve range: 0.31-1,250 pg/mL
(IL-8)

standard curve range: 0.31-1,250 pg/mL
(MIP-1α)

standard curve range: 0.37-1,500 pg/mL
(IL-7)

standard curve range: 0.43-1,750 pg/mL
(TNFα)

standard curve range: 0.49-2,000 pg/mL
(IL-1β)

standard curve range: 0.49-2,000 pg/mL
(IL-12 (p70))

standard curve range: 0.49-2,000 pg/mL
(IL-2)

standard curve range: 0.49-2,000 pg/mL
(IL-5)

standard curve range: 0.61-2,500 pg/mL
(IFNγ)

standard curve range: 0.61-2,500 pg/mL
(MIP-3α)

standard curve range: 0.73-3,000 pg/mL
(IL-17A)

standard curve range: 0.92-3,750 pg/mL
(MIP-1β)

standard curve range: 1.22-5,000 pg/mL
(GM-CSF)

standard curve range: 1.46-6,000 pg/mL
(IL-10)

standard curve range: 1.46-6,000 pg/mL
(ITAC)

standard curve range: 1.83-7,500 pg/mL
(IL-4)

standard curve range: 18.3-75,000 pg/mL
(Fractalkine)

standard curve range: 7.93-32,500 pg/mL
(IL-23)

inter-assay cv: <20%
intra-assay cv: <10%

テクニック

multiplexing: suitable

適合性

configured for Premixed

検出方法

fluorometric (Luminex xMAP)

輸送温度

ambient

詳細

Cytokines are immunomodulatory polypeptides that play key roles in both adaptive and innate immune responses. A generic term, “cytokines” includes myokines (produced by muscle cells), lymphokines (produced by activated Th cells), interleukins (acting as mediators between T cells) and chemokines (responsible for T-cell migration). One of the regulatory mechanisms of the immune system, cytokines act at the recognition, activation, or effector phases of an immune response, modulating the development and functional activities of the subtypes of T cells, B cells and myeloid cells. Consequently, research involving cytokines plays a significant role in achieving a deeper understanding of the immune system and its multi-faceted response to most antigens, especially those responses that make up the inflammatory process.

Low levels of inflammation are involved in many clinical and sub-clinical disease states, such as autoimmune disease, cardiovascular disease, diabetes, neurological disorders, and cancer. Measuring picogram levels of cytokines, therefore, is critical for understanding the pathogenesis of these diseases.

The 384-well Human High Sensitivity T Cell Panel is the 384-well version of the current 96-well Human High Sensitivity T Cell Panel, and it exceeds expectations in terms of throughput, sensitivity and sample detectability.

The MILLIPLEX® 384-well Human High Sensitivity T Cell Panel is to be used for the simultaneous quantification of any or all of the above analytes in serum, plasma, or tissue/cell culture supernatant: Fractalkine/CX3CL1, GM-CSF, IFN-γ, IL-1beta, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8/CXCL8, IL-10, IL-12 (p70), IL-13, IL17A/CTLA8, IL-21, IL-23, ITAC/EXCL11, MIP-1α/CCL3, MIP-1β/CCL4, MIP-3α/CCL20 and TNFα.

The Luminex® xMAP® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.

Panel Type: Cytokines/Chemokines

特異性

Cross Reactivty
There is no detectable cross-reactivity within the panel.
Cross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.

アプリケーション

  • Analytes: Fractalkine, GM-CSF, IFNγ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p70), IL-13, IL-17A, IL-21, IL-23, I-TAC, MIP-1α, MIP-1β, MIP-3α, TNF-α
  • Because there are unique features concerning sample prep and assay set-up, please read the entire protocol before running the assay.
  • Recommended Sample type: Serum, plasma or tissue/cell lysate and culture supernatant
  • Assay Run Time: Overnight
  • Research Category: Inflammation & Immunology
  • Research Subcategory: Immune Response, Metabolic Disorders, Chronic Inflammatory Disease, Cardiovascular Disease, Neuroscience

保管および安定性

Recommended storage for kit components is 2 - 8°C.

その他情報

Please contact Technical Service for linearity of dilution.
Sensitivity: Please see kit protocol for individual assay sensitivities.

法的情報

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

ピクトグラム

Health hazardCorrosionExclamation markEnvironment

シグナルワード

Danger

危険有害性の分類

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

ターゲットの組織

Respiratory Tract

保管分類コード

10 - Combustible liquids


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

毒物及び劇物取締法

キットコンポーネントの情報を参照してください

PRTR

キットコンポーネントの情報を参照してください

消防法

キットコンポーネントの情報を参照してください

労働安全衛生法名称等を表示すべき危険物及び有害物

キットコンポーネントの情報を参照してください

労働安全衛生法名称等を通知すべき危険物及び有害物

キットコンポーネントの情報を参照してください

カルタヘナ法

キットコンポーネントの情報を参照してください

Jan Code

キットコンポーネントの情報を参照してください


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Philip C Spinella et al.
Frontiers in immunology, 11, 2085-2085 (2020-10-06)
The hemostatic properties of tranexamic acid (TXA) are well described, but the immunological effects of TXA administration after traumatic injury have not been thoroughly examined. We hypothesized TXA would reduce monocyte activation in bleeding trauma patients with severe injury. This

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)